Not surprised. We finally get a trail update and it's a fizzer.
2 and a half years and only half way through a 25 patient trial. At this rate we could expect final results sometime in 2026.
Results so far underwhelming and investigator having to lower the starting dose due to tolerability issues.
Ann: Preliminary update from ongoing Phase 2 Study of Paxalisib, page-3
Add to My Watchlist
What is My Watchlist?